Precigen to present at the jmp securities life sciences conference

Germantown, md,, june 10, 2021 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced helen sabzevari, phd, president and ceo of precigen, will participate in a fireside chat at the annual jmp securities life sciences conference on thursday, june 17, 2021 at 11:00 am et.  participants may access the live webcasts of the virtual events through precigen's website in the events & presentations section at investors.precigen.com/events-presentations.
PGEN Ratings Summary
PGEN Quant Ranking